Literature DB >> 6294719

Lithium does not prevent ECS-induced decreases in beta-adrenergic receptors.

B Birmaher, B Lerer, R H Belmaker.   

Abstract

Electroconvulsive shock (ECS) reduces the number of rat cortical beta-adrenergic receptors. Lithium has been reported in several systems to prevent receptor changes induced by other agents. However, the present experiment reports that chronic lithium does not prevent the reduction in dihydroalprenolol binding induced by ten daily ECS treatments.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6294719     DOI： 10.1007/bf00432261

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  12 in total

1.  Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain.

Authors:  D A Bergstrom; K J Kellar
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

2.  The effect of imipramine and lithium on alpha- and beta-receptor binding in rat brain.

Authors:  J E Rosenblatt; C B Pert; J F Tallman; A Pert; W E Bunney
Journal:  Brain Res       Date:  1979-01-05       Impact factor: 3.252

3.  A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain.

Authors:  J Vetulani; R J Stawarz; J V Dingell; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

4.  The effects of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. A double-blind, multicenter trial.

Authors:  O Lingjaerde; A H Edlund; C A Gormsen; C G Gottfries; A Haugstad; I L Hermann; P Hollnagel; A Mäkimattilla; K E Rasmussen; J Remvig; O H Robak
Journal:  Acta Psychiatr Scand       Date:  1974       Impact factor: 6.392

5.  Regional alterations in rat brain neurotransmitter systems following chronic lithium treatment.

Authors:  A Maggi; S J Enna
Journal:  J Neurochem       Date:  1980-04       Impact factor: 5.372

6.  Complications with electroconvulsive treatment combined with lithium.

Authors:  J G Small; J J Kellams; V Milstein; I F Small
Journal:  Biol Psychiatry       Date:  1980-02       Impact factor: 13.382

7.  Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity.

Authors:  D A Staunton; P J Magistretti; W J Shoemaker; F E Bloom
Journal:  Brain Res       Date:  1982-01-28       Impact factor: 3.252

8.  Lithium does not prevent agonist-induced subsensitivity of human adenylate cyclase.

Authors:  J Zohar; B Lerer; R P Ebstein; R H Belmaker
Journal:  Biol Psychiatry       Date:  1982-03       Impact factor: 13.382

9.  Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study.

Authors:  F M Quitkin; J Kane; A Rifkin; J R Ramos-Lorenzi; D V Nayak
Journal:  Arch Gen Psychiatry       Date:  1981-08

10.  Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.

Authors:  A Pert; J E Rosenblatt; C Sivit; C B Pert; W E Bunney
Journal:  Science       Date:  1978-07-14       Impact factor: 47.728
View more
  1 in total

1.  Investigation of the influence of lithium upon the down-regulation of serotonin2 receptors in rat frontal cortex induced by long-term treatment with dibenzepin, an antidepressant without appreciable affinity to serotonin2 receptors.

Authors:  A Closse; A L Jaton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.